Recent Canadian experience with targeted hepatitis C virus lookback

Transfusion

Volumn 46, Issue 5, 2006, Pages 690-694

  Goldman, Mindy ^a   Patterson, Lindsay ^b   Long, Anne ^b  

^a CBS   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBODY SCREENING; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CANADA; ENZYME IMMUNOASSAY; EXPERIENCE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; RECIPIENT; SCREENING TEST; SEROCONVERSION;

BLOOD BANKS; BLOOD DONORS; BLOOD TRANSFUSION; CANADA; DONOR SELECTION; FEMALE; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RETROSPECTIVE STUDIES; RNA, VIRAL;

EID: 33646244002     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2006.00786.x     Document Type: Article

References (21)

1. Lauer GM Walker BD Hepatitis C virus infection N Engl J Med 2001 345 41 52
2. Chou R Clark EC Helfand M Screening for Hepatitis C virus infection: a review of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 2004 40 465 79
3. Alter MJ Kruszon-Moran D Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 1999 341 556 62
4. Goldman M Juodvalkis S Gill P Spurll G Hepatitis C lookback Transfus Med Rev 1998 12 84 93
5. Long A Spurll G Demers H Goldman M Targeted hepatitis C lookback: Quebec, Canada Transfusion 1999 39 194 200
6. Culver DH Alter MJ Mullan RJ Margolis HS Evaluation of the effectiveness of targeted lookback for HCV infection in the United States - interim results Transfusion 2000 40 1176 81
7. Menozzi D Udulutch T Llosa AE Galel SA HCV lookback in the United States: effectiveness of an extended lookback program Transfusion 2000 40 1393 8
8. Kleinman S Busch MP Korelitz JJ Schreiber GB The incidence/window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection Transfus Med Rev 1997 11 155 72
9. Schreiber GB Busch MP Kleinman SH Korelitz JJ The risk of transfusion-transmitted viral infections N Engl J Med 1996 334 1685 90
10. Stramer SL Glynn SA Kleinman SH et al. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing N Engl J Med 2004 351 760 8
11. Kleinman S Chan P Robillard P Risks associated with transfusion of cellular blood components in Canada Transfus Med Rev 2003 17 120 62
12. Goldman M Spurll G Hepatitis C lookback Curr Opin Hematol 2000 7 392 6
13. Minister of Public Works and Government Services. 1995 Preliminary Report from the Commission of Inquiry on the Blood System in Canada Toronto, Canada Minister of Public Works and Government Services 1995.
14. Abbott PRISM HCV package insert Abbott Park (IL) Abbott Laboratories 2001
15. Guidance for Industry: current good manufacturing practice for blood and blood components: (1) quarantine and disposition of units from prior collections from donors with repeatedly reactive screening tests for antibody to hepatitis C virus (anti-HCV); (2) supplemental testing, and the notification of consignees and blood recipients of donor test results for anti-HCV Rockville (MD) Center for Biologics Evaluation and Research (CBER), Food and Drug Administration 1998
16. Sepkowitz KA Risk to cancer patients from nosocomial hepatitis C virus Infect Control Hosp Epidemiol 2004 25 599 602
17. Finelli L Miller JT Tokars JI Alter MJ Arduino MJ National surveillance of dialysis-associated diseases in the United States, 2002 Semin Dial 2005 18 52 61
18. Larke B Hu YW Krajden M et al. Acute nosocomial HCV infection detected by NAT of a regular blood donor Transfusion 2002 42 759 65
19. Callum JL Pinkerton PH Coovadia AS Thomson AE Dewsbury F An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients Transfusion 2000 40 1169 75
20. Epstein J Hepatitis C virus lookback: emerging science and public policy [editorial] Transfusion 2000 40 3 5
21. AuBuchon JP Paving with good intentions: learning from HCV lookback [editorial] Transfusion 2000 40 1153 6